Also Known As:
3-(tetraacetyl glucopyranos-2-yl)-1-(2- chloroethyl)-1-nitrosourea
relevant articles (0 outcomes,
Bio-Agent Context: Research Results
|1. ||Neoplasms (Cancer)
- "The major endpoint assessed was tumor cure and was grouped as follows: (1) high (greater than or equal to 80%), achieved with BCNU, MeCCNU, CCNU, CLZ, ACNU, FCNU, PCNU, and cis-acid; (2) medium (40- less than 80%), obtained with GANU, NSC-88104, and GCNU, and (3) low or nil (less than 40%), shown by CNU and STZN.
Related Drugs and Biologics